The True Value of HbA1c as a Predictor of Diabetic Complications: Simulations of HbA1c Variables

被引:60
|
作者
Lind, Marcus [1 ]
Oden, Anders [1 ]
Fahlen, Martin [2 ]
Eliasson, Bjorn [3 ]
机构
[1] Chalmers Univ Technol, Dept Math Sci, Gothenburg, Sweden
[2] Kungalv Hospital, Dept Med, Kungalv, Sweden
[3] Sahlgrens Univ Hosp, Dept Internal Med, Gothenburg, Sweden
来源
PLOS ONE | 2009年 / 4卷 / 02期
关键词
CORONARY-HEART-DISEASE; HEALTH-CARE BURDEN; HEMOGLOBIN; MODELS; RISK;
D O I
10.1371/journal.pone.0004412
中图分类号
O [数理科学和化学]; P [天文学、地球科学]; Q [生物科学]; N [自然科学总论];
学科分类号
07 ; 0710 ; 09 ;
摘要
Aim: The updated mean HbA1c has been used in risk estimates of diabetic complications, but it does not take into account the temporal relationship between HbA1c and diabetic complications. We studied whether the updated mean HbA1c underestimated the risk of diabetic complications. Method: Continuous HbA1c curves for 10,000 hypothetical diabetes patients were simulated over an average of 7 years. Simulations were based on HbA1c values encountered in clinical practice. We assumed that each short time interval of the continuous HbA1c curves had a long-lasting effect on diabetic complications, as evidenced by earlier studies. We tested several different HbA1c variables including various profiles, e.g. different duration, of such a long-lasting effect. The predictive power of these variables was compared with that of the updated mean HbA1c. Results: The predictive power of the constructed HbA1c variables differed considerably compared to that of the updated mean HbA1c. The risk increase per standard deviation could be almost 100% higher for a constructed predictor than the updated mean HbA1c. Conclusions: The importance of good glycemic control in preventing diabetic complications could have been underestimated in earlier hallmark studies by not taking the time-dependent effect of HbA1c into account.
引用
收藏
页数:6
相关论文
共 50 条
  • [1] A systematic review of HbA1c variables used in the study of diabetic complications
    Lind, Marcus
    Oden, Anders
    Fahlen, Martin
    Eliasson, Bjorn
    [J]. DIABETES & METABOLIC SYNDROME-CLINICAL RESEARCH & REVIEWS, 2008, 2 (04) : 282 - 293
  • [2] HbA1c is outcome predictor in diabetic patients with sepsis
    Gornik, Ivan
    Gornik, Olga
    Gasparovic, Vladimir
    [J]. DIABETES RESEARCH AND CLINICAL PRACTICE, 2007, 77 (01) : 120 - 125
  • [3] What Is the True HbA1c? A HbA1C Peak in the Absence of HbA in an Adult Patient without Sickle Cell Disease
    Harris, Neil S.
    Marin, Maximo J.
    Winter, William E.
    [J]. JOURNAL OF APPLIED LABORATORY MEDICINE, 2023, 8 (02): : 425 - 428
  • [4] Biological Variables Impact on the HbA1c Level: An Algorithm to Help Individualise HbA1c Targets
    Hsieh, Albert
    Mcgill, Margaret
    Molyneaux, Lynda
    Constantino, Maria
    Yue, Dennis
    Twigg, Stephen
    [J]. DIABETES, 2012, 61 : A214 - A214
  • [6] HbA1c as a predictor for response of bevacizumab in diabetic macular oedema
    Sharma, Sadhana
    Joshi, Sagun Narayan
    Karki, Pratap
    [J]. BMJ OPEN OPHTHALMOLOGY, 2020, 5 (01):
  • [7] What Is Behind the HbA1c Value?
    Tanaka, Atsushi
    Node, Koichi
    [J]. JOURNAL OF THE AMERICAN COLLEGE OF CARDIOLOGY, 2021, 78 (15)
  • [8] CYTOMETRY OF HBA1C
    Malergue, F.
    Van Agthoven, A.
    Godefroy, C.
    Rabellino, E. M.
    [J]. HAEMATOLOGICA, 2016, 101 : 870 - 871
  • [9] Haemoglobin A1c (HbA1C) in non-diabetic and diabetic vascular patients. Is HbA1C an independent risk factor and predictor of adverse outcome?
    O'Sullivan, C. J.
    Hynes, N.
    Mahendran, B.
    Andrews, E. J.
    Avalos, G.
    Tawfik, S.
    Lowery, A.
    Sultan, S.
    [J]. EUROPEAN JOURNAL OF VASCULAR AND ENDOVASCULAR SURGERY, 2006, 32 (02) : 188 - 197
  • [10] HbA1c and beyond
    Rossing, Peter
    [J]. NEPHROLOGY DIALYSIS TRANSPLANTATION, 2023, 38 (01) : 34 - 40